Hemispherx Biopharma Announces First Patient Treated in Phase 2 Ovarian Cancer Clinical Trial Evaluating Ampligen in Combination with Pembrolizumab and Cisplatin

June 12, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search